Jefferies lowered the firm’s price target on Varonis (VRNS) to $60 from $75 and keeps a Buy rating on the shares. The end of life for the 24% of ARR that is on-premise by the end of 2026 was “surprising,” but there is precedent of “ripping the Band-Aid off SaaS conversions” unlocking shareholder value, as long as there’s no competitive issues and management is adamant there’s not, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis Systems: Strategic Adjustments Amidst Challenges Support Buy Rating
- Varonis price target lowered to $50 from $70 at Barclays
- Varonis Systems: Buy Rating Affirmed Amid SaaS Growth and Strategic Adjustments
- Varonis Systems Reports Strong SaaS Growth Amid Strategic Shifts
- Closing Bell Movers: Bloom Energy, Teradyne both up 20% on earnings